Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy

By Sa-Filho D.J.   Costa L.J.   de Oliveira C.F.   Guimaraes A.P.C.   Accetturi C.V.A.   Tanuri A.   Diaz R.S.  

Journal of Clinical Virology, Vol. 28, Iss. 2, 2003-10 ,pp. : 186-202

Elsevier

Access to resources Recommend Favorite

Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL study

By Masiá Mar   Martínez Esteban   Padilla Sergio   Gatell José M.   Gutiérrez Félix  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 409-413

Oxford University Press

Access to resources Recommend Favorite

Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance

By Babrzadeh Farbod   Varghese Vici   Pacold Mary   Liu Tommy F.   Nyrén Pål   Schiffer Celia   Fessel W. Jeffrey   Shafer Robert W.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 414-418

Oxford University Press

Access to resources Recommend Favorite

White coat phenomenon, anxiety and endothelial function in healthy normotensive elderly subjects

By Murata Tetsuhito   Narita Kosuke   Hamada Toshihiko   Takahashi Tetsuya   Omori Masao   Yoshida Haruyoshi   Wada Yuji  

Blood Pressure, Vol. 15, Iss. 2, 2006-04 ,pp. : 88-92

Informa Healthcare

Access to resources Recommend Favorite

Vascular endothelial toxicity induced by HIV protease inhibitor: Evidence of oxidant-related dysfunction and apoptosis

By Baliga Reshma   Liu Cynthia   Hoyt Dale   Chaves Alysia   Bauer John  

Cardiovascular Toxicology, Vol. 4, Iss. 2, 2004-06 ,pp. : 199-206

Humana Press, Inc

Access to resources Recommend Favorite